Ikarian Capital’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-274,009	Closed	-$2.79M	–	131
2025 Q1	$2.79M	Buy	+274,009	New	+$2.79M	0.34%	35